Effect of probenecid on the disposition of captopril and captopril dimer in the rat.
The urinary excretion of captopril has been studied in a bladder-cannulated rat model and compared with that obtained after co-administration with probenecid. Probenecid reduced significantly the urinary excretion of captopril from 41% to 21% of the administered dose over a 3-hr period and significantly lowered urine flow rates. In addition, the effect of probenecid on plasma levels of captopril and total captopril (captopril plus disulfides) after oral administration of the disulfide prodrug captopril dimer (10 mg/kg) has been studied in a conscious rat preparation. Co-administration of probenecid (20 mg/kg) given either orally or intravenously increased both the plasma levels of captopril and total captopril (captopril plus captopril disulfides) over a 4-hr period. A prolonged significant inhibition of plasma ACE after co-administration of probenecid and captopril dimer suggests that probenecid may be useful to prolong the action of captopril or the prodrug captopril dimer.
D000818:Animals; D002216:Captopril / Q000097:blood* / Q000652:urine; D007700:Kinetics; D008297:Male; D007703:Peptidyl-Dipeptidase A / Q000097:blood; D011339:Probenecid / Q000494:pharmacology*; D011392:Proline / Q000031:analogs & derivatives*; D051381:Rats; D011921:Rats, Inbred WKY
D011392:Proline; D002216:Captopril; D007703:Peptidyl-Dipeptidase A; D011339:Probenecid